United-Guardian Shareholders Reaffirm Board, Pay, and Auditor
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
United-Guardian ( (UG) ) just unveiled an announcement.
At its annual meeting of stockholders held on May 13, 2026, United-Guardian shareholders re-elected all seven director nominees to the board, maintaining continuity in the company’s leadership and governance. Investors also opted to hold say-on-pay votes on executive compensation every year, approved the current executive pay program on an advisory basis, and ratified Grassi & Co., CPAs P.C. as the independent auditor for the 2026 fiscal year, signaling broad shareholder support for existing oversight and compensation practices.
Spark’s Take on UG Stock
According to Spark, TipRanks’ AI Analyst, UG is a Outperform.
UG scores well primarily due to strong financial quality (debt-free balance sheet and strong cash conversion) and attractive valuation (low P/E and high dividend yield). Technicals are supportive with price above key moving averages and positive MACD, though momentum indicators are largely neutral and the main risk is uneven multi-year growth and margin consistency.
To see Spark’s full report on UG stock, click here.
More about United-Guardian
United-Guardian, Inc. is a specialty chemicals company that develops and manufactures cosmetic ingredients, personal care products, pharmaceuticals, and medical lubricants for global consumer and healthcare markets. Its portfolio supports customers in the beauty, health, and medical sectors, positioning the company as a niche supplier within the broader specialty chemicals and personal care industries.
Average Trading Volume: 4,718
Technical Sentiment Signal: Sell
Current Market Cap: $32.94M
Find detailed analytics on UG stock on TipRanks’ Stock Analysis page.
